Economically challenged Emergent reached out to Bavarian Nordic in travel vaccine talks
Though the Danish vaccine company has been on the lookout for potential acquisitions for some time, it wasn’t the first to spot a potential trade with Emergent, says CFO Henrik Juuel.
by christian bundgaard, translated by daniel pedersen
It began with some noncommittal talks in November 2022, which increased in scope through December and January.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
